Analysts: Accretive Health Inc (AH)


AH on New York Consolidated

11.10USD
19 Jun 2013
Price Change (% chg)

$-0.04 (-0.36%)
Prev Close
$11.14
Open
$11.17
Day's High
$11.27
Day's Low
$11.08
Volume
432,399
Avg. Vol
473,962
52-wk High
$14.19
52-wk Low
$8.55

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.11 December 20 Jun 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 2 1 1 1
(3) HOLD 4 4 4 5
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.62 2.50 2.50 2.56

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 6 253.87 261.90 242.50 270.67
Quarter Ending Sep-13 6 267.41 277.75 254.75 287.72
Year Ending Dec-13 8 1,056.10 1,095.42 1,005.98 1,120.88
Earnings (per share)
Quarter Ending Jun-13 6 0.11 0.13 0.09 0.15
Quarter Ending Sep-13 6 0.12 0.14 0.10 0.18
Year Ending Dec-13 8 0.47 0.55 0.38 0.63
LT Growth Rate (%) 1 30.00 30.00 30.00 24.25

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-12 231.18 223.13 8.04 3.48
Quarter Ending Jun-12 234.64 236.69 2.05 0.87
Quarter Ending Mar-12 231.05 253.74 22.69 9.82
Quarter Ending Dec-11 254.27 260.08 5.81 2.29
Quarter Ending Sep-11 222.26 218.89 3.37 1.51
Earnings (per share)
Quarter Ending Sep-12 0.05 0.06 0.01 12.57
Quarter Ending Jun-12 0.08 0.03 0.05 60.89
Quarter Ending Mar-12 0.06 0.06 0.00 1.69
Quarter Ending Dec-11 0.16 0.17 0.01 5.52
Quarter Ending Sep-11 0.12 0.11 0.01 9.84

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 253.87 253.87 254.69 253.87 270.67
Quarter Ending Sep-13 267.41 267.41 268.76 267.41 287.72
Year Ending Dec-13 1,056.10 1,056.10 1,060.77 1,056.10 1,120.88
Earnings (per share)
Quarter Ending Jun-13 0.11 0.11 0.11 0.11 0.15
Quarter Ending Sep-13 0.12 0.12 0.12 0.12 0.18
Quarter Ending Dec-13 0.47 0.47 0.47 0.47 0.63

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-13 0 0 0 0
Quarter Ending Sep-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Earnings
Quarter Ending Jun-13 0 0 0 0
Quarter Ending Sep-13 0 0 0 0
Year Ending Dec-13 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks